Moscow Healthcare Department Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2017
NCT03137927
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Infectious Disease Clinical Hospital No. 1 of the Moscow Healthcare Department | Moscow Healthcare Department

Active Ingredients

Drugs in Phase 3 Trials (2)

gam-covid-vac (rad26) (1 trial)

gam-covid-vac (rad5) (1 trial)

Drugs in Phase 2 Trials (1)

gamlpv (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Whooping Cough (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3